These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6620110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics of theophylline and ethylenediamine following single and repeated doses of a sustained-release aminophylline preparation to volunteers.
    Cotgreave IA, Caldwell J.
    J Pharm Pharmacol; 1985 Sep; 37(9):618-21. PubMed ID: 2867181
    [Abstract] [Full Text] [Related]

  • 4. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB, Guarnone E, Bartoli A, Ciardelli L, Piacentini P.
    Minerva Med; 1985 Mar 31; 76(13):641-5. PubMed ID: 3991030
    [Abstract] [Full Text] [Related]

  • 5. A multiple-dose study of sustained-release theophylline and aminophylline.
    Meyer MC, Straughn AB, Lieberman P.
    Chest; 1980 Aug 31; 78(2):300-3. PubMed ID: 7398417
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 31; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 7. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec 31; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE, Munsiff IJ, McKiernan BC.
    J Vet Pharmacol Ther; 1989 Dec 31; 12(4):369-77. PubMed ID: 2614856
    [Abstract] [Full Text] [Related]

  • 9. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A, Bakke OM, Vigander T.
    Br J Clin Pharmacol; 1981 Mar 31; 11(3):269-73. PubMed ID: 7213528
    [Abstract] [Full Text] [Related]

  • 10. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH, van der Boon WJ, Balant LP, Schoenmaker R, Holtkamp A.
    Eur J Clin Pharmacol; 1984 Mar 31; 26(2):215-22. PubMed ID: 6723760
    [Abstract] [Full Text] [Related]

  • 11. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU, Steinijans VW, Gabel H.
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov 31; 22(11):621-5. PubMed ID: 6500759
    [Abstract] [Full Text] [Related]

  • 12. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar 31; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R, Billing B.
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb 31; 21(2):69-72. PubMed ID: 6840927
    [Abstract] [Full Text] [Related]

  • 14. Temporal variations in trough serum theophylline concentrations at steady state.
    Lesko LJ, Brousseau D, Canada AT, Eastwood G.
    J Pharm Sci; 1980 Mar 31; 69(3):358-9. PubMed ID: 7381723
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB, Schwartz RH, Brooks JG.
    Ann Allergy; 1983 Mar 31; 50(3):161-5. PubMed ID: 6829982
    [Abstract] [Full Text] [Related]

  • 16. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I, Bialer M, Salame K, Bar-On H.
    Eur J Clin Pharmacol; 1984 Mar 31; 26(3):401-3. PubMed ID: 6734702
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of sustained release theophylline in low and high multidose regimens.
    Koëter GH, Jonkman JH, de Vries K, Schoenmaker R, Greving JE, de Zeeuw RA.
    Br J Clin Pharmacol; 1981 Nov 31; 12(5):647-51. PubMed ID: 7332728
    [Abstract] [Full Text] [Related]

  • 18. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr 31; 24(4):196-201. PubMed ID: 3710632
    [Abstract] [Full Text] [Related]

  • 19. Theophylline: biochemical pharmacology and pharmacokinetics.
    Trembath PW, Boobis SW, Richens A.
    J Int Med Res; 1979 Apr 31; 7 Suppl 1():4-15. PubMed ID: 220119
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S, Raina RK, Samotra K, Gupta KL.
    Indian J Chest Dis Allied Sci; 1991 Apr 31; 33(1):1-8. PubMed ID: 1791015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.